Chronic methamphetamine intoxication model of schizophrenia in animals

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Clinical and neurochemical parallels between methamphetamine (MAP) psychosis and schizophrenia were noted post-WWII, particularly during Japanese MAP abuse epidemics.
• This led to the development of an animal model simulating chronic MAP intoxication.

Purpose of the Study:

• To outline and validate a chronic methamphetamine (MAP) intoxication model in animals for studying schizophrenia.
• To investigate the behavioral disorders and relapse liability in this animal model.

Main Methods:

• Chronic administration of low-dose methamphetamine (MAP) via daily injections to various animal species over weeks or months.
• Behavioral assessments in animals, including monkeys, to observe psychotic and autistic behaviors.

Main Results:

• Animal models exhibited disorders similar to human MAP abusers and chronic schizophrenia, including psychotic and enduring autistic behaviors.
• Monkeys displayed perceptual-cognitive disturbances underlying psychotic behaviors.
• Observed high relapse liability in psychotic behaviors, recurring with drug re-administration or stress.

Conclusions:

• The chronic MAP intoxication model effectively replicates key behavioral aspects of schizophrenia in animals.
• This model is valuable for studying the mechanisms of psychosis and relapse in schizophrenia.
• Further research can explore the relationship between chronic MAP intoxication and acute amphetamine stereotypy models.